ZTS - Zoetis Inc.

NYSE - NYSE Delayed Price. Currency in USD
94.91
-0.46 (-0.48%)
At close: 4:03PM EST
Stock chart is not supported by your current browser
Previous Close95.37
Open94.75
Bid70.20 x 1300
Ask0.00 x 1300
Day's Range94.56 - 95.29
52 Week Range77.00 - 96.57
Volume2,251,444
Avg. Volume2,441,249
Market Cap45.44B
Beta (3Y Monthly)0.67
PE Ratio (TTM)32.39
EPS (TTM)2.93
Earnings DateFeb 13, 2019 - Feb 18, 2019
Forward Dividend & Yield0.66 (0.70%)
Ex-Dividend Date2019-04-17
1y Target Est100.09
Trade prices are not sourced from all markets
  • TheStreet.com16 hours ago

    Zoetis Is in a Strong Uptrend So Don't Expect Much of a Dip to Buy It

    In his second "Executive Decision" segment of Mad Money Friday night, Jim Cramer sat down with Juan Ramon Alaix, CEO of Zoetis Inc. ZTS is an animal health company with shares that vaulted 9.8% last week after another strong quarter. Alaix added that Zoetis has effective treatments for a number of conditions, including ticks, fleas, heartworm and other parasites.

  • Thomson Reuters StreetEventsyesterday

    Edited Transcript of ZTS earnings conference call or presentation 14-Feb-19 1:30pm GMT

    Q4 2018 Zoetis Inc Earnings Call

  • Moody's4 days ago

    Zoetis Inc. -- Moody's announces completion of a periodic review of ratings of Zoetis Inc.

    Announcement: Moody's announces completion of a periodic review of ratings of Zoetis Inc. New York, February 15, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Zoetis Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Zoetis Inc (ZTS) Q4 2018 Earnings Conference Call Transcript
    Motley Fool5 days ago

    Zoetis Inc (ZTS) Q4 2018 Earnings Conference Call Transcript

    ZTS earnings call for the period ending December 31, 2018.

  • Fido's Drugmaker Nears Breakout After Topping Quarterly Estimates
    Investor's Business Daily6 days ago

    Fido's Drugmaker Nears Breakout After Topping Quarterly Estimates

    Shares of animal health outlet Zoetis popped Thursday after Zoetis earnings and sales easily topped fourth-quarter expectations. Zoetis stock is approaching a potential buy point.

  • Zoetis (ZTS) Beats on Q4 Earnings & Sales, Shares Up
    Zacks6 days ago

    Zoetis (ZTS) Beats on Q4 Earnings & Sales, Shares Up

    Zoetis (ZTS) exceeds both earnings and sales expectations in the fourth quarter of 2018.

  • Barrons.com6 days ago

    Zoetis Stock Gains Because People Keep Spending on Their Pets

    The company, the largest publicly traded animal-health business, earned more than expected and issued an encouraging forecast for the current year.

  • Zoetis (ZTS) Tops Q4 Earnings and Revenue Estimates
    Zacks6 days ago

    Zoetis (ZTS) Tops Q4 Earnings and Revenue Estimates

    Zoetis (ZTS) delivered earnings and revenue surprises of 2.60% and 3.14%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press6 days ago

    Zoetis: 4Q Earnings Snapshot

    On a per-share basis, the Parsippany, New Jersey-based company said it had profit of 71 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to 79 cents ...

  • Business Wire6 days ago

    Zoetis Reports Fourth Quarter and Full Year 2018 Results

    Zoetis $ZTS announces Q4 and full year 2018 financial results

  • Benzinga7 days ago

    Zoetis Q4 Earnings Preview

    On Thursday, Feb. 14, Zoetis (NYSE: ZTS ) will release its latest earnings report. Benzinga's outlook for Zoetis is included in the following report. Earnings and Revenue Zoetis EPS is expected to be around ...

  • Business Wire8 days ago

    Zoetis Declares Second Quarter 2019 Dividend

    Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future use of cash and dividend payments, and other future events.

  • Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
    Zacks8 days ago

    Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?

    Zoetis Inc. (ZTS) is gearing up to report fourth-quarter 2018 results. The company continues to strengthen its diverse product portfolio through lifecycle innovations, strong customer relationships, and access to new markets and technologies.

  • Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake
    Zacks9 days ago

    Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake

    Eli Lilly (LLY) to initiate an exchange offer for shareholders to divest its remaining ownership interest in Elanco

  • Barrons.com12 days ago

    Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health

    The drug giant announced on Friday that it will unload the remaining shares it holds of Elanco Animal Health through a voluntary stock-exchange offer.

  • Markit12 days ago

    See what the IHS Markit Score report has to say about Zoetis Inc.

    Zoetis Inc NYSE:ZTSView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ZTS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZTS. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ZTS totaled $14.89 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks13 days ago

    Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Have Insiders Been Selling Zoetis Inc. (NYSE:ZTS) Shares?
    Simply Wall St.22 days ago

    Have Insiders Been Selling Zoetis Inc. (NYSE:ZTS) Shares?

    It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples Read More...

  • GlobeNewswire22 days ago

    Detailed Research: Economic Perspectives on Pitney Bowes, Zoetis, Rent-A-Center, Live Nation Entertainment, Everbridge, and KB Home — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Jan. 29, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Why the Earnings Surprise Streak Could Continue for Zoetis (ZTS)
    Zackslast month

    Why the Earnings Surprise Streak Could Continue for Zoetis (ZTS)

    Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Business Wire2 months ago

    Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2018 Financial Results

    Zoetis Inc. will host a webcast and conference call at 8:30 a.m. on Thursday, Feb. 14, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review fourth quarter and full year 2018 financial results and respond to questions from financial analysts during the call.

  • Barrons.com2 months ago

    Eli Lilly and Pfizer Are Boosting Dividends

    It’s been a solid year for dividend hikes among large-cap pharmaceutical companies, which are often popular among income investors.

  • Zoetis CEO on health care for animals: Brazil is growing 'very fast'
    CNBC Videos4 days ago

    Zoetis CEO on health care for animals: Brazil is growing 'very fast'

    Jim Cramer sits down with Zoetis CEO Juan Ramos Alaix to discuss how parents pay for their pets' health care and a future product launch.